Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-13-050892

Options or other derivatives

  • Chief Scientific Officer acquired 985,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

THOMPSON JOHN PHD · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-09-13 Grant or award : show line 1 in the form Common Stock Option +985,000 $0.05 2023-09-13 985,000 2,203,276 D
Loading xslF345X03/form462246_20130916115145-.xml…